Mihalis S Kariolis

Title: **Innovating with Knottin Peptides: The Contributions of Mihalis S. Kariolis**

Introduction

Mihalis S. Kariolis, based in Stanford, California, is a notable inventor recognized for his groundbreaking work in the field of protein chemistry. With an impressive portfolio of 14 patents, Kariolis has significantly contributed to the development of fusion proteins and their applications, leveraging his expertise to innovate within the biotechnology sector.

Latest Patents

Among his latest patents is the concept of "Fusion proteins comprising an engineered knottin peptide and uses thereof." This innovative approach focuses on engineering existing protein-protein interactions through domain addition and evolution. It encompasses the creation of novel fusion proteins that incorporate knottin peptides, with portions of these peptides replaced with sequences designed for binding to specific targets. The versatility of these fusion proteins allows for bispecific or multispecific functionalities, enabling them to bind to and inhibit multiple receptors or receptor ligands simultaneously. Furthermore, these proteins can be enhanced by fusing knottins with existing ligands or receptors to increase the affinity of interactions or create novel protein constructs that improve expression and folding.

Career Highlights

Kariolis has worked at prestigious institutions, including Leland Stanford Junior University and Aravive Biologics, Inc. His work at these organizations has facilitated his research and development efforts, allowing him to push the boundaries of what is possible in protein engineering and therapeutics.

Collaborations

Throughout his career, Mihalis has collaborated with esteemed colleagues, including Amato J. Giaccia and Jennifer R. Cochran. These partnerships have contributed to broadening his research impact and advancing innovative solutions within the biotechnology landscape.

Conclusion

Mihalis S. Kariolis is a leading inventor whose work on knottin peptides and fusion proteins holds significant promise for therapeutic applications. His continued commitment to innovation and collaboration highlights the important role of inventors in driving advancements in science and technology.